世界中西医结合杂志
世界中西醫結閤雜誌
세계중서의결합잡지
WORLD JOURNAL OF TRADITIONAL CHINESE AND WESTERN MEDICINE
2014年
6期
629-631
,共3页
感冒后咳嗽%愈咳方%咳嗽%风盛挛急证
感冒後咳嗽%愈咳方%咳嗽%風盛攣急證
감모후해수%유해방%해수%풍성련급증
Cough after Common Cold%Yuke Formula%Cough%Excessive Wind and Spasm Pattern/ Syndrome
目的：评价愈咳方治疗感冒后咳嗽的临床疗效及安全性。方法160例符合入组标准的患者随机分为治疗组（110例）与对照组（50例），治疗组应用中药愈咳方治疗，对照组常规西药治疗，两组疗程均为10 d。观察两组患者的总有效率及起效时间。结果治疗组中西医症状疗效总有效率为90.0%与92.7%，对照组为70.0%与66.0%，两组比较差异有统计学意义（P ﹤0.01）。治疗组平均起效时间为（2.95±1.24）d，对照组为（3.86±1.87）d，两组比较差异有统计学意义（ P ﹤0.05）。结论愈咳方治疗感冒后咳嗽安全、有效，值得推广。
目的：評價愈咳方治療感冒後咳嗽的臨床療效及安全性。方法160例符閤入組標準的患者隨機分為治療組（110例）與對照組（50例），治療組應用中藥愈咳方治療，對照組常規西藥治療，兩組療程均為10 d。觀察兩組患者的總有效率及起效時間。結果治療組中西醫癥狀療效總有效率為90.0%與92.7%，對照組為70.0%與66.0%，兩組比較差異有統計學意義（P ﹤0.01）。治療組平均起效時間為（2.95±1.24）d，對照組為（3.86±1.87）d，兩組比較差異有統計學意義（ P ﹤0.05）。結論愈咳方治療感冒後咳嗽安全、有效，值得推廣。
목적：평개유해방치료감모후해수적림상료효급안전성。방법160례부합입조표준적환자수궤분위치료조（110례）여대조조（50례），치료조응용중약유해방치료，대조조상규서약치료，량조료정균위10 d。관찰량조환자적총유효솔급기효시간。결과치료조중서의증상료효총유효솔위90.0%여92.7%，대조조위70.0%여66.0%，량조비교차이유통계학의의（P ﹤0.01）。치료조평균기효시간위（2.95±1.24）d，대조조위（3.86±1.87）d，량조비교차이유통계학의의（ P ﹤0.05）。결론유해방치료감모후해수안전、유효，치득추엄。
Objective To evaluate the clinical efficacy and safety of Yuke Formula in the treatment of cough after common cold. Methods One hundred and sixty cases in compliance with the inclusive criteria were randomized into a treatment group(110 cases)and a control group(50 cases). In the treatment group, Yuke Formula was used. In the control group,the conventional western medicine was applied. The duration of treatment was 10 days in the two groups. The total effective rate and onset time were observed in the two groups. Results The efficacy on the symptoms of Chinese and western medicine and the total effective rate were 90. 0% and 92. 7% in the treatment group,and were 70. 0% and 66. 0% in the control group separate-ly,indicating the significant difference(P ﹤ 0. 01). The average onset time was(2. 95 ± 1. 24)d in the treat-ment group and was(3. 86 ± 1. 87)d in the control group,indicating the significant difference in comparison (P ﹤ 0. 05). Conclusion Yuke Formula is safe and effective in the treatment of cough after common cold and deserves to be promoted.
